Public Company News

Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration

SHANGHAI, Dec. 4, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). It is indicated for the treatment of meta...

2021-12-04 01:51 333

Chindata Group Announces Leadership Change

BEIJING, Dec. 3, 2021 /PRNewswire/ -- Chindata Group Holdings Limited ("Chindata Group" or the "Company") (Nasdaq: CD), a leading carrier-neutral hyperscale data center solution provider inAsia-Pacific emerging markets, today announced its Chief Executive Officer ("CEO"), Mr.Jing Ju, effective...

2021-12-03 23:04 642

EZGO's Affiliate Company Obtains Exclusive Rights to Operate E-Bicycle Sharing Services in Tancheng, Shandong

CHANGZHOU, China, Dec. 3, 2021 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we", "our", or "the Company"), a manufacturer of two- and three-wheeled electric vehicles inChina, today announced that an affiliate company of the Company's PRC subsidiary has entered into an operati...

2021-12-03 22:29 573

China Liberal Education Holdings Limited Reports Financial Results for the First Six Months of Fiscal Year 2021

BEIJING, Dec. 3, 2021 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal", or the "Company", or "we"), a China-based company that provides smart campus solutions and other educational services, today announced its financial results for the first six months of ...

2021-12-03 21:30 616

Infobird upgrades its intelligent interactive training product

BEIJING, Dec. 3, 2021 /PRNewswire/ -- Infobird Co., Ltd (Nasdaq: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions in China, announced that it has upgraded its cloud-based intelligent in...

2021-12-03 21:30 595

I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors

SHANGHAI and GAITHERSBURG, Md., Dec. 3, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first two patients have been dosed in the U.S. p...

2021-12-03 21:00 679

MKD to harness Industrial IOT capabilities

SHANGHAI, Dec. 3, 2021 /PRNewswire/ -- Dr. Dongliang Chang, Chairman of the Board of Directors of Molecular Data Inc. (NASDAQ:MKD), has been appointed the Dean of the Institute for Industrial Internet of Things(IOT) Industry Research, Hangzhou Institute for Advanced Studies, UCAS (hereinafter ref...

2021-12-03 20:30 690

36Kr Holdings Inc. to Report Third Quarter 2021 Financial Results on Thursday, December 9, 2021

BEIJING, Dec. 3, 2021 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today announced that it will report its third quarter 2021 unaudited financial results, onThursday,...

2021-12-03 20:20 678

FPT Techday 2021 Thrive in The Green Normal

HANOI, Vietnam, Dec. 3, 2021 /PRNewswire/ -- FPT, ranked among Southeast Asia's most prominent technology businesses, recently held the Annual Technology Forum - FPT Techday 2021 under the theme "Thrive in The Green Normal." The event attracted over 100,000 attendees, including over 5,000 enterpr...

2021-12-03 20:13 654

BMO Financial Group Reports Fourth Quarter and Fiscal 2021 Results

Fourth Quarter 2021 Earnings Release BMO's 2021 audited annual consolidated financial statements and accompanying Management Discussion and Analysis (MD&A) are available online at www.bmo.com/investorrelations and at www.sedar.com . Financial Results Highlights Fourth Quarter 2021 Compared With...

2021-12-03 19:58 753

BMO Financial Group Announces Intention to Repurchase Up to 22.5 Million of its Common Shares

TORONTO, Dec. 3, 2021 /PRNewswire/ -- Bank of Montreal (TSX: BMO) (NYSE: BMO) today announced its intention, subject to the approval of the Office of the Superintendent of Financial Institutions Canada (OSFI) and the Toronto Stock Exchange (TSX), to purchase for cancellation up to 22.5 million of...

2021-12-03 19:40 567

BMO Financial Group Increases Common Share Dividend by 27 cents from the prior quarter, up 25 per cent from the prior quarter and prior year

TORONTO, Dec. 3, 2021 /CNW/ - Bank of Montreal (TSX: BMO) (NYSE: BMO) today announced that its Board of Directors declared a quarterly dividend of$1.33 per share on paid-up common shares of Bank ofMontreal for the first quarter of fiscal year 2022 ("Q1 2022 Dividend"), a27 cent increase from the ...

2021-12-03 19:03 541

Onion Global Will Launch Eyelicious Cosmetic Contact Lens Brand

GUANGZHOU, China, Dec. 3, 2021 /PRNewswire/ -- Onion Global Limited ("Onion Global", the "Group" or the "Company") (NYSE: OG), a next-generation lifestyle brand platform that incubates, markets, and distributes the world's fresh, fashionable, and future brands to young people inChina and across A...

2021-12-03 18:00 889

Elekta's new sustainability-linked bond oversubscribed

STOCKHOLM, Dec. 3, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has issuedSEK 1.5 billion senior unsecured sustainability-linked bonds under its Medium Term Note Program (MTN-Program). One of the bonds, in the amount of SEK 1,150 million, has a maturity of 5 years with a coupon ...

2021-12-03 14:54 755

Marriott International Signs Agreement with Kyushu Railway Company to Bring the Marriott Hotels Brand to Nagasaki

TOKYO, Dec. 3, 2021 /PRNewswire/ -- Marriott International Inc. today announced the signing of an agreement with Kyushu Railway Company to debut the company's signature brand –Marriott Hotels – in Nagasaki, Japan. Once opened, Nagasaki Marriott will mark th...

2021-12-03 14:30 930

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

* Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE™ inVietnam * The agreement includes a minimum commitment of 1 million units in the first year * VIRALEZE™ is scheduled to be officially launched in Vietnam today, following its registration for sale this week ...

2021-12-03 14:24 762

RemeGen's Telitacicept and Disitamab Vedotin Enter China's National Reimbursement Drug List for SLE and Gastric Cancer Treatment

YANTAI, China, Dec. 3, 2021 /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, today announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic lupus erythematosus (SLE) and a novel antibody-dru...

2021-12-03 13:45 845

Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications

SAN FRANCISCO, INDIANAPOLIS, and SUZHOU, China, Dec. 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and ...

2021-12-03 12:37 1150

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy

HANGZHOU, China and SHAOXING, China, Dec. 3, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that its all-oral direct anti-hepatitis C virus (HCV) ASCLEVIR® (Ravidasvir)/ GANOVO® (Danoprevir) regimen has been included in the Medicine Catalog for National Basic Medical Insu...

2021-12-03 12:05 945

InnoCare Announces Inclusion of Orelabrutinib in China National Reimbursement Drug List

BEIJING, Dec. 2, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biotech company, announced today that its BTK inhibitor orelabrutinib has been included in the updated National Reimbursement Drug List (NRDL) by the China National Healthcare Security Administration (NHSA). ...

2021-12-03 10:13 748
12345 ... 1179